Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $108.3600 (0.91%) ($107.0900 - $109.1400) on Thu. Dec. 24, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.12% (three month average) | RSI | 53 | Latest Price | $108.3600(0.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) XBI(57%) IWO(56%) IWM(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.56% in a week (0% probabilities). VIXM(-17%) TLT(-16%) UUP(-7%) GDXJ(-5%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.56% (StdDev 3.12%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
5 Day Moving Average | $108.2(0.15%) | 10 Day Moving Average | $107.84(0.48%) | 20 Day Moving Average | $107.52(0.78%) | To recent high | -3.1% | To recent low | 32% | Market Cap | $1.741b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |